Work

First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors

Year: 2018

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-018-0646-1

Authors: Kathleen N. Moore, Johanna C. Bendell, Patricia M. LoRusso, Anthony J. Olszanski, Esther Zwick-Wallasch, Mendel Jansen, Alexander G. Vandell, Giorgio Senaldi

Institutions: Sarah Cannon, Tennessee Oncology, OU Health Stephenson Cancer Center, University of Oklahoma, Wayne State University, Fox Chase Cancer Center, Laboratoire Adhésion et inflammation, Daiichi Sankyo (United Kingdom), Daiichi Sankyo (United States)

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: CANCER CENTER SUPPORT GRANT

OpenAlex ID: W2884932646

FWCI: 0.314

Cites: 25

Cited by: 6

Related to: 10